Zimmer Biomet (NYSE:ZBH) said yesterday it tapped former Covidien investor relations head Coleman Lannum as its investor relations senior VP, reporting directly to prez & CEO Bryan Hanson. Lannum has more than 15 years in investor relations, having held positions with Mallinckrodt Pharmaceuticals (NYSE:MNK), Covidien and Tyco Healthcare. During his time with Covidien, Lannum oversaw the company’s initial […]
Tyco Healthcare
Device makers take more than $1B in Defense Dept. contracts
The United States Department of Defense awarded nearly $1.1 billion worth of contracts to 3 medical device firms.
Covidien could be on the hook for nearly $450M in back taxes
Covidien wins $177M from Johnson & Johnson’s Ethicon Endo-Surgery in ultrasound scalpel spat
UPDATED March 29, 2013, with comment from Covidien.
Covidien forebear Tyco pays $26M to settle overseas bribery beef
Report: J&J set for EU OK on Synthes buyout | Wall Street Beat
European Union regulators are poised to give the OK to Johnson & Johnson‘s (NYSE:JNJ) $21.3 billion acquisition of Swiss orthopedic giant Synthes, according to Reuters.
Meelia era ends at Covidien as Almeida set to take over company
Meelia
Richard Meelia, the CEO who led Covidien plc (NYSE:COV) in its various incarnations for more than two decades will hand over the keys to the corner officer to José (Joe) Almeida today without fanfare.
Meelia, 62, was named president & CEO of Covidien in June 2007, after it was spun out of the disintegrating Tyco International. He was elected chairman in October 2008 and has been with the company in its different forms for 20 years.
DePuy Pinnacle hip implant lawsuits consolidated in Texas | Legal Roundup
A group of at least 57 product liability lawsuits filed against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics over one of its metal-on-metal hip implants were consolidated in the U.S. District Court for Northern Texas.
Tyco Healthcare to settle sharps disposal case for $33 million
Tyco Healthcare, the corporate ancestor of Covidien plc (NYSE:COV), agreed to pay $32.5 million to settle a class-action antitrust lawsuit filed by a Louisiana hospital and a drug company accusing it of seeking to monopolize the market for the disposal of needles and syringes.
The Natchitoches Parish Hospital Service District and Smith Drug Co. sued Tyco in the U.S. District Court for Massachusetts, accusing Tyco of entering into exclusive purchasing contracts for sharps containers with individual customers and group purchasing organizations. Under the terms of the latter deals, the GPOs allegedly agreed not to broker sharps container sales by Tyco’s competitors.
